Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Simon Spichak, MSc
Blue Pee Fiasco: Alzheimer’s Pill Has Colorful, Complicating Side Effect
Settling the Diet Soda and Dementia Debate — For Now
Study: Alzheimer’s Trials Are Basically Designed for White People
Could Alzheimers’ Best Known Biomarker Actually Be a Brain Protector?
The Next Disease-Modifying Alzheimer’s Drug? Lecanemab Trial Results Looking Good
An Electric Jolt to the Brain May Boost Memory—But Don’t Get Too Fired Up
Genetic Origami: How Misfolded DNA Could Lead to Alzheimer’s
Far Out: New Psychedelic for Alzheimer’s Depression Heads to Trials
The Brain That Defied Alzheimer’s
The 1% Throw Down Millions to Fix Alzheimer’s Diagnostics
Can Multivitamins Prevent Cognitive Aging? Here’s the Real Story
Dementia Companion: Robo Caregivers Are Coming to Help
How Much Does Aduhelm Cost?
What Do Cholesterol, Gut Disorders and Alzheimer’s Have in Common? Genes.
Falling May Be An Early Sign of Dementia
Previous
24
25
26
Next
Page load link
Go to Top